CAY10679 is primarily utilized in biochemical research as a selective inhibitor of the enzyme soluble epoxide hydrolase (sEH). Its application is significant in studies focused on understanding the role of sEH in various physiological and pathological processes, particularly in inflammation, cardiovascular diseases, and pain management. By inhibiting sEH, CAY10679 helps to stabilize epoxyeicosatrienoic acids (EETs), which are known to have anti-inflammatory, vasodilatory, and analgesic effects. This makes it a valuable tool in exploring potential therapeutic strategies for conditions such as hypertension, atherosclerosis, and chronic pain. Additionally, CAY10679 is used in pharmacological studies to evaluate the efficacy and mechanisms of sEH inhibition in cellular and animal models, contributing to the development of novel treatments targeting sEH-related pathways.